Preparation of protein transduction domain-fused peptidyl prolyl cis/trans isomerase pin1

Bioscience, Biotechnology and Biochemistry

Volumn 74, Issue 10, 2010, Pages 2067-2070

  Ohashi, Tsubasa ^a   Teshima, Sumito ^a   Hidaka, Masafumi ^a   Uchiday, Takafumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Cell cycle; Peptidyl prolyl cis trans isomerase Pin1; Protein transduction domain human immunodeficiency virus 1 trans actuvatir if transcription factor (TAT)

Indexed keywords

CELL CYCLE; FUSION PROTEINS; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS-1; ISOMERASES; MACROMOLECULAR DRUGS; MOUSE EMBRYONIC FIBROBLASTS; PROTEIN TRANSDUCTION DOMAINS; S-PHASE;

BACTERIOPHAGES; CELL CULTURE; DISEASES; TRANSCRIPTION;

TRANSCRIPTION FACTORS;

HYBRID PROTEIN; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDE FRAGMENT; PEPTIDYLPROLYL ISOMERASE; TRANSACTIVATOR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CELL CYCLE S PHASE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; GENETICS; HELA CELL; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PROTEIN ENGINEERING; PROTEIN TRANSPORT;

AMINO ACID SEQUENCE; ANIMALS; HELA CELLS; HUMANS; MICE; MODELS, MOLECULAR; PEPTIDE FRAGMENTS; PEPTIDYLPROLYL ISOMERASE; PROTEIN ENGINEERING; PROTEIN TRANSPORT; RECOMBINANT FUSION PROTEINS; S PHASE; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 78049413628     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.100372     Document Type: Article

References (17)

1. Takahashi K, Uchida C, Shin RW, Shimazaki K, and Uchida T, Cell. Mol. Life Sci., 65, 359-375 (2008).
2. Lu KP, Hanes SD, and Hunter T, Nature, 380, 544-547 (1996).
3. Fujimori F, Takahashi K, Uchida C, and Uchida T, Biochem. Biophys. Res. Commun., 265, 658-663 (1999).
4. Liou YC, Ryo A, Huang HK, Lu PJ, Bronson R, Fujimori F, Uchida T, Hunter T, and Lu KP, Proc. Natl. Acad. Sci. USA, 99, 1335-1340 (2002).
5. Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, Volina S, Ronai Z, Blandino G, Schneider C, and Del Sal G, Nature, 419, 853-857 (2002).
6. Zheng H, You H, Zhou XZ, Murray SA, Uchida T, Wulf G, Gu L, Tang X, Lu KP, and Xiao ZX, Nature, 419, 849-853 (2002).
7. Yeh ES and Means AR, Nat. Rev. Cancer, 7, 381-388 (2007).
8. Nechama M, Uchida T, Yosef-Levi IM, Silver J, and Naveh-Many T, J. Clin. Invest., 119, 3103-3114 (2009).
9. Park J, Ryu J, Kim KA, Lee HJ, Bahn JH, Han K, Choi EY, Lee KS, Kwon HY, and Choi SY, J. Gen. Viol., 83, 1173-1181 (2002).
10. Derossi D, Joliot AH, Chassaing G, and Prochiantz A, J. Biol. Chem., 269, 10444-10450 (1994).
11. Kuhnel F, Schulte B, Wirth T, Woller N, Scafers S, Zender L, Manns M, and Kubica S, J. Virol., 78, 13734-13754 (2004).
12. Shen WC and Ryser HJ, Proc. Natl. Acad. Sci. USA, 75, 1872-1876 (1978).
13. Mitchell DJ, Kim DT, Steinman L, Fathman CG, and Rothbard JB, J. Pept. Res., 56, 318-325 (2000).
14. Avraham HK, Jiang S, Lee TH, Prakash O, and Avraham S, J. Immunol., 173, 6228-6233 (2004).
15. Fanghänel J, Akiyama H, Uchida C, and Uchida T, FEBS Lett., 580, 3237-3245 (2006).
16. Tatara Y, Lin YC, Bamba Y, Mori T, and Uchida T, Biochem. Biophys. Res. Commun., 384, 394-398 (2009).
17. Shen ZJ, Esnault S, Rosenthal L, Szakaly R, Sorkness R, Westmark P, Sandor M, and Malter J, J. Clin. Invest., 118, 479-490 (2008).